1.8700
+0.1200
+(6.86%)
At close: January 13 at 4:00:02 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.57M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| OSTROWSKI ERIK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.26 per share. | Direct | 15,140 | May 13, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.26 per share. | Direct | 43,898 | May 13, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.58 per share. | Direct | 11,327 | Feb 29, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.58 per share. | Direct | 73,581 | Feb 29, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.58 per share. | Direct | 9,439 | Feb 29, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.58 per share. | Direct | 13,684 | Feb 29, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.52 per share. | Direct | 12,718 | Feb 27, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.52 per share. | Direct | 57,354 | Feb 27, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.52 per share. | Direct | 11,265 | Feb 27, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.52 per share. | Direct | 16,331 | Feb 27, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.68 per share. | Direct | 40,842 | Feb 1, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.68 per share. | Direct | 78,102 | Feb 1, 2024 |
| BURKE STEVEN KEITH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| BUTLER JOHN P Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| GRUND NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| MALABRE RICHARD C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.15 per share. | Direct | 31,050 | Aug 25, 2023 |
| SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 31, 2023 |
| ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| HADAS NICOLE R Officer | Sale at price 1.22 per share. | Direct | 77,270 | May 25, 2023 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.22 per share. | Direct | 116,760 | May 25, 2023 |
| HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| BURKE STEVEN KEITH Officer | Sale at price 1.07 per share. | Direct | 67,890 | May 16, 2023 |
| SPELLMAN DAVID A. Chief Financial Officer | Sale at price 1.07 per share. | Direct | 67,890 | May 16, 2023 |
| HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 12, 2023 |
| DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 12, 2023 |
| BURKE STEVEN KEITH Officer | Sale at price 0.88 per share. | Direct | 12,393 | Mar 1, 2023 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 0.88 per share. | Direct | 80,614 | Mar 1, 2023 |
| HADAS NICOLE R Officer | Sale at price 0.88 per share. | Direct | 11,437 | Mar 1, 2023 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 0.88 per share. | Direct | 17,912 | Mar 1, 2023 |
| SPELLMAN DAVID A. Chief Financial Officer | Sale at price 0.88 per share. | Direct | 6,327 | Mar 1, 2023 |
Related Tickers
AQST Aquestive Therapeutics, Inc.
3.1100
+0.97%
ESPR Esperion Therapeutics, Inc.
2.2800
-2.56%
AVDL Avadel Pharmaceuticals plc
7.82
-1.01%
BFRI Biofrontera Inc.
1.1300
+0.89%
ETON Eton Pharmaceuticals, Inc.
14.00
+4.17%
PTPI Petros Pharmaceuticals, Inc.
0.3450
-8.27%
DVAX Dynavax Technologies Corporation
12.48
-1.19%
ASRT Assertio Holdings, Inc.
0.8069
-3.53%
SCYX SCYNEXIS, Inc.
1.1800
-4.07%
SXTC China SXT Pharmaceuticals, Inc.
0.4220
-12.08%